|
- Hemophilia: What to know about your treatment options
Typically, factor mimetic or rebalancing therapies are given by injection on a set schedule Many of the newer non-factor products are good options for people who develop a clotting factor antibody, called an inhibitor, that makes factor replacement therapy more challenging
- List of Treatments for Hemophilia | MyHemophiliaTeam
Advate (Antihemophilic factor [recombinant]) Overview Advate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A Advate can also be used for… read more
- AHF (Antihemophilic Factor): Uses Side Effects - Cleveland Clinic
AHF (antihemophilic factor) is a medication that prevents or manages bleeding if you have hemophilia A This condition keeps your blood from clotting as it should so you bleed more than expected A healthcare provider will usually give you this injection in a hospital or clinic setting
- Antihemophilic factor (intravenous route) - Mayo Clinic
Description Antihemophilic factor (AHF) injection is used to treat, control, prevent, and decrease the frequency of bleeding episodes, and prevent bleeding during surgery in patients with hemophilia A (congenital Factor VIII deficiency) Antihemophilic factor (AHF) is a protein that is produced naturally in the body It helps the blood form clots to stop bleeding and prevents bleeding problems
- Hemophilia Therapies - Rare Disease Advisor
Read more about Wilate Xyntha Xyntha ® (antihemophilic factor [recombinant]) is a recombinant factor VIII indicated for the on-demand treatment, perioperative management, and routine prophylaxis of bleeding in patients with hemophilia A It temporarily replaces FVIII in patients with hemophilia A to aid in hemostasis
- Approved Treatments for Hemophilia – Hemophilia News Today
Obizur (susoctocog alfa) is a recombinant, or man-made, antihemophilic factor therapy approved for the on-demand treatment of bleeds in adults with acquired hemophilia A
- Antihemophilic Factor (Human) (Monograph) - Drugs. com
Antihemophilic Factor (Human) reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI)
- Hemophilia Rare Bleeding Disorders Treatment Info | novoMEDLINK™
Novoeight ® (antihemophilic factor, recombinant) is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis to reduce the frequency of bleeding episodes
|
|
|